Health Canada inspection
Aurium Pharma Inc.: Health Canada inspection of Jan 24, 2026
Health Canada · GMP · rating C
Key facts
| Establishment | Aurium Pharma Inc. |
|---|---|
| City | Toronto |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Jan 13, 2026 |
| End date | Jan 24, 2026 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101292 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.